September 22, 2018

At Late Breaking Trials of TCT 2018, Leaders Free in USA + Canada was successfully presented!

BioFreedom keeps showing superior Safety and Efficacy against BMS in HBR patients.

Results are comparable to Leader Free I.

•  Patients in Leaders Free presented worst baseline characteristcs: They are younger and higher Body Mass Index than European patients.

•  In this set of worst patients BioFreedom has outstanding results.

•  High adoption of Radial Access and more than 98% of Device Success – Strut Thickness again is not a problem to cross the lesion or implant the stent (slide attached).


← All events